Publishing Scientific Papers with Potential Security Risks
The recent controversy over publication of scientific papers concerning the transmissibility of bird flu virus was reviewed in a new report by the Congressional Research Service. The report cautiously elucidates the relevant policy implications and considers the responses available to Congress.
“Because of the complexity of dual-use issues, analysis of a topic according to one set of policy priorities may lead to unforeseen complications due to its intersection with other policy priorities,” the report says. “For example, maximizing security may lead to detriments in public health and scientific advancement, while maximizing scientific advancement may lead to security risks.”
See Publishing Scientific Papers with Potential Security Risks: Issues for Congress, July 12, 2012.
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.